Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000583401 | SCV000690191 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-06-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001235830 | SCV001408535 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-03-01 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821703 | SCV002069141 | uncertain significance | not specified | 2018-04-24 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004568295 | SCV005054990 | uncertain significance | Endometrial carcinoma | 2023-12-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000583401 | SCV005145579 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-04-25 | criteria provided, single submitter | clinical testing | The p.V424L variant (also known as c.1270G>C), located in coding exon 4 of the MSH6 gene, results from a G to C substitution at nucleotide position 1270. The valine at codon 424 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV005001086 | SCV005625623 | uncertain significance | not provided | 2024-06-19 | criteria provided, single submitter | clinical testing | The MSH6 c.1270G>C (p.Val424Leu) variant has not been reported in individuals with MSH6-related conditions in the published literature. The frequency of this variant in the general population, 0.000008 (2/251340 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded conflicting predictions that this variant is benign or damaging. Based on the available information, we are unable to determine the clinical significance of this variant. |